Comment re: "Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping"
Pancreatology
.
2017 May-Jun;17(3):354-355.
doi: 10.1016/j.pan.2017.04.006.
Epub 2017 Apr 12.
Authors
A Wannhoff
1
,
K H Weiss
1
,
T Hackert
2
,
D N Gotthardt
3
Affiliations
1
Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany.
2
Department of General, Visceral and Transplant Surgery, University Hospital Heidelberg, Heidelberg, Germany.
3
Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany. Electronic address: daniel.gotthardt@gotthardt.com.
PMID:
28434838
DOI:
10.1016/j.pan.2017.04.006
No abstract available
Publication types
Editorial
Comment
MeSH terms
CA-19-9 Antigen*
Genotype*
Humans
Pancreatic Neoplasms
Substances
CA-19-9 Antigen